by Bill Malloy | Feb 5, 2024 | Cancer, Medication, Pharmaceuticals
A recent Phase III clinical trial for a cancer vaccine called DCVax showed that it could provide patients with extra years beyond their initial prognoses. The vaccine is used to treat glioblastoma, one of the most common, aggressive, and deadly forms of brain cancer....
by Bill Malloy | Feb 5, 2024 | Cancer, Scientists
A recent study out of the University of Texas Southwestern Simmons Cancer Center showed that lactate—a metabolic byproduct produced during exercise—could be used to enhance cancer immunotherapy. The researchers believe that lactate could be used to rejuvenate...
by Bill Malloy | Jan 23, 2024 | Cancer, Medication, Pharmaceuticals
The world became familiar with Messenger RNA (mRNA) vaccines during the COVID-19 pandemic, as this was the technology used to develop COVID vaccines so quickly. However, this vaccine technology was originally designed to be used against cancer. A recent study...
by Bill Malloy | Jan 23, 2024 | Cancer, Health
At the San Antonio Breast Cancer Symposium in December 2022, a French group of scientists presented the results of a trial that could help oncologists make better treatment decisions for patients with metastatic breast cancer. According to the trial, counting the...
by Bill Malloy | Nov 14, 2023 | Cancer
Researchers from the University of Tokyo recently made a discovery that they believe could be a breakthrough in the fight against cancer. The researchers tested artificial DNA as a weapon for targeting and destroying cancer cells, and the results were encouraging. The...
by Bill Malloy | Aug 15, 2023 | Cancer, Health, Pharmaceuticals
A recent immunotherapy clinical trial by the Memorial Sloan Kettering Cancer Center (MSK) yielded unprecedented results—remission for every single participant. While it was a small trial with 14 participants, the results are extremely encouraging. According to MSK...
